Show 10 5 10 15 20 50 100 250 Sort by year (new to old) Actions Download search results Subscribe to news feed Your filters: cql: author="Lang, F" or (type any "bookEditor issueEditor" and editor="Lang, F") Add to list Conference Paper C3 Phase I, first-in-human trial of BI 836826 (an anti-CD37 antibody) in patients (PTS) with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) S Stilgenbauer, T Aurran Schleinitz, M Hallek, F Lang, Fritz Offner (UGent) , J-F Rossi, W Schroyens, E Van Den Neste, L Ysebaert, P Blum, et al. (2015) HAEMATOLOGICA. 100(suppl. 1). p.225-226